May 17, 2020

Malpractice is still rife with the use of Electronic Health Records, report finds.

Technology
healthcare services
electronic health records
healthcare services
Catherine Sturman
2 min
EHR
Malpractice is still rife with the use of Electronic Health Records, report finds.

A recent study by The Doctors Company has found that the use of Elec...

Malpractice is still rife with the use of Electronic Health Records, report finds.

A recent study by The Doctors Company has found that the use of Electronic Health Records has contributed to a number of patient injuries over the last 10 years.

Committed to supporting practices in the management of complexities surrounding modern healthcare, with expert guidance, resources, and coverage, The Doctors Company has become one of the largest physician-owned medical malpractice insurers, with 80,000 members and over $4 billion in assets.

The rise of digitisation is slowly transforming the healthcare sector since the implementation of the Health Information Technology for Economic and Clinical Health Act, especially within the realms of EHR management. However, it has also provided increased concerns surrounding the sharing of patient data, medicine management and patient safety across the board

The study has shown that claims in which EHR is a factor has risen from just two incidents from 2007-2008, to 161 from 2011-2016, a staggering increase.

The study also looks at the number of claims submitted from 2014 to 2016, and linked them with a previous study. Issues highlight ongoing challenges surrounding the integration of hospital EHR systems, such as the increasing number of data inputting errors which are repeatedly impacting patient care.

Related stories

"This study makes an important contribution by chronicling actual errors, such as wrong medications selected from an auto pick list, and helps point the way to changes ranging from physician education to EHR software design,” comments Robert M. Wachter, MD, Professor and Chair, Department of Medicine, University of California, San Francisco.

Whilst the implementation of EHR platforms has opened the doors to a number of advantages in the healthcare industry, such as enabling health professionals to access information in real time and greater communication between various medical teams, the report highlights that there is still some work to be done surrounding the integration of such technology.

"Awareness of basic EMR risks can provide opportunities for organizational and medical staff leadership to adopt appropriate procedural and technical safeguards to avert or mitigate them," explained Joyce Benton, Assistant Vice President, Risk Control, CNA Healthcare.

"Even an employee's simple use of the copy and paste function of EMR systems creates patient safety and compliance challenges. The goal is to ensure that EMR technology serves as a problem-solver, rather than a problem-creator."

Share article

Jun 18, 2021

Skin Analytics wins NHSX award for AI skin cancer tool 

AI
NHS
skincancer
Cancer
2 min
Skin Analytics uses AI to detect skin cancer and will be deployed across the NHS to ease patient backlogs

An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system. 

NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion. 

Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making. 

In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog. 

Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening. 

DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.

Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.

Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges. 

"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”

Share article